420 related articles for article (PubMed ID: 24947722)
1. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations.
Lindman BR; Stewart WJ; Pibarot P; Hahn RT; Otto CM; Xu K; Devereux RB; Weissman NJ; Enriquez-Sarano M; Szeto WY; Makkar R; Miller DC; Lerakis S; Kapadia S; Bowers B; Greason KL; McAndrew TC; Lei Y; Leon MB; Douglas PS
JACC Cardiovasc Interv; 2014 Jun; 7(6):662-73. PubMed ID: 24947722
[TBL] [Abstract][Full Text] [Related]
2. Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.
Chau KH; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
J Am Coll Cardiol; 2020 May; 75(19):2446-2458. PubMed ID: 32408979
[TBL] [Abstract][Full Text] [Related]
3. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
Oh JK; Lee SH; Lee SA; Kang DY; Lee S; Kim HJ; Ahn JM; Kim JB; Park DW; Song JM; Choo SJ; Kang DH; Song JK; Park SJ; Kim DH
Int J Cardiol; 2021 Jun; 332():60-66. PubMed ID: 33781852
[TBL] [Abstract][Full Text] [Related]
5. Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function.
Dahiya G; Kyvernitakis A; Joshi AA; Lasorda DM; Bailey SH; Raina A; Biederman RWW; Kanwar MK
Int J Cardiovasc Imaging; 2021 Feb; 37(2):485-492. PubMed ID: 32902782
[TBL] [Abstract][Full Text] [Related]
6. Small Left Ventricle and Clinical Outcomes After Transcatheter Aortic Valve Replacement.
Saito T; Inohara T; Yoshijima N; Yashima F; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Yamawaki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K
J Am Heart Assoc; 2021 Apr; 10(7):e019543. PubMed ID: 33749309
[TBL] [Abstract][Full Text] [Related]
7. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
[TBL] [Abstract][Full Text] [Related]
8. Incidence and sequelae of prosthesis-patient mismatch in transcatheter versus surgical valve replacement in high-risk patients with severe aortic stenosis: a PARTNER trial cohort--a analysis.
Pibarot P; Weissman NJ; Stewart WJ; Hahn RT; Lindman BR; McAndrew T; Kodali SK; Mack MJ; Thourani VH; Miller DC; Svensson LG; Herrmann HC; Smith CR; Rodés-Cabau J; Webb J; Lim S; Xu K; Hueter I; Douglas PS; Leon MB
J Am Coll Cardiol; 2014 Sep; 64(13):1323-34. PubMed ID: 25257633
[TBL] [Abstract][Full Text] [Related]
9. B-type natriuretic peptide is associated with remodeling and exercise capacity after transcatheter aortic valve replacement for aortic stenosis.
Sato K; Kumar A; Krishnaswamy A; Mick S; Desai MY; Griffin BP; Kapadia SR; Popović ZB
Clin Cardiol; 2019 Feb; 42(2):270-276. PubMed ID: 30565264
[TBL] [Abstract][Full Text] [Related]
10. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
Elmariah S; Palacios IF; McAndrew T; Hueter I; Inglessis I; Baker JN; Kodali S; Leon MB; Svensson L; Pibarot P; Douglas PS; Fearon WF; Kirtane AJ; Maniar HS; Passeri JJ;
Circ Cardiovasc Interv; 2013 Dec; 6(6):604-14. PubMed ID: 24221391
[TBL] [Abstract][Full Text] [Related]
12. Determinants of Left Ventricular Mass Regression in Patients with Severe Symptomatic Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation.
Weissler-Snir A; Shapira Y; Sagie A; Kazum S; Assali A; Vaknin-Assa H; Bental T; Codner P; Orvin K; Kornowski R; Vaturi M
J Heart Valve Dis; 2015 May; 24(3):272-9. PubMed ID: 26901894
[TBL] [Abstract][Full Text] [Related]
13. Impact of transcatheter aortic valve implantation on the left ventricular mass.
Kasapkara HA; Ayhan H; Sarı C; Aslan AN; Süygün H; Baştuğ S; Durmaz T; Keleş T; Bozkurt E
Cardiol J; 2015; 22(6):645-50. PubMed ID: 26004938
[TBL] [Abstract][Full Text] [Related]
14. Reversibility of Cardiac Function Predicts Outcome After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis.
Sato K; Kumar A; Jones BM; Mick SL; Krishnaswamy A; Grimm RA; Desai MY; Griffin BP; Rodriguez LL; Kapadia SR; Obuchowski NA; Popović ZB
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28698259
[TBL] [Abstract][Full Text] [Related]
15. Echocardiographic Results of Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients: The PARTNER 3 Trial.
Pibarot P; Salaun E; Dahou A; Avenatti E; Guzzetti E; Annabi MS; Toubal O; Bernier M; Beaudoin J; Ong G; Ternacle J; Krapf L; Thourani VH; Makkar R; Kodali SK; Russo M; Kapadia SR; Malaisrie SC; Cohen DJ; Leipsic J; Blanke P; Williams MR; McCabe JM; Brown DL; Babaliaros V; Goldman S; Szeto WY; Généreux P; Pershad A; Alu MC; Xu K; Rogers E; Webb JG; Smith CR; Mack MJ; Leon MB; Hahn RT;
Circulation; 2020 May; 141(19):1527-1537. PubMed ID: 32272848
[TBL] [Abstract][Full Text] [Related]
16. Women had favourable reverse left ventricle remodelling after TAVR.
Chen SC; Leu HB; Chang HH; Chen IM; Chen PL; Lin SM; Chen YH
Eur J Clin Invest; 2020 Jan; 50(1):e13183. PubMed ID: 31691961
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic determinants of LV functional improvement after transcatheter aortic valve replacement.
Chen J; Nawaz N; Fox Z; Komlo C; Anwaruddin S; Desai N; Jagasia D; Herrmann HC; Han Y
Catheter Cardiovasc Interv; 2016 May; 87(6):1164-72. PubMed ID: 27145743
[TBL] [Abstract][Full Text] [Related]
18. Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement.
Abdelghani M; Abdel-Wahab M; Hemetsberger R; Landt M; Merten C; Toelg R; Richardt G
Int J Cardiol; 2019 Aug; 288():39-43. PubMed ID: 30948219
[TBL] [Abstract][Full Text] [Related]
19. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
[TBL] [Abstract][Full Text] [Related]
20. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
